TNXP · NASDAQ
Tonix Pharmaceuticals Holding (TNXP) Stock Price & Fundamentals
Tonix Pharmaceuticals Holding (TNXP) closed at $530.86 on Oct 9, 2026, down 0.96% from the previous close of $536.02.
Share price, past year
1Y +27.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $530.86 |
| Sep 30, 2026 | $532.79 |
| Aug 31, 2026 | $531.31 |
| Jul 31, 2026 | $521.29 |
| Jun 30, 2026 | $542.90 |
| May 29, 2026 | $539.10 |
| Apr 30, 2026 | $512.29 |
| Mar 31, 2026 | $490.70 |
| Feb 27, 2026 | $470.70 |
| Jan 30, 2026 | $457.50 |
| Dec 31, 2025 | $435.13 |
| Nov 28, 2025 | $441.42 |
| Oct 31, 2025 | $429.82 |
Key statistics
- Market cap
- $8.91B
- P/E (TTM)
- —
- EPS (TTM)
- −$13.24
- Revenue (TTM)
- $29.10M
- Net income (TTM)
- −$159.67M
- Shares outstanding
- 16.8M
- Dividend yield
- —
- 52-week range
- $413.65 – $557.79
Tonix Pharmaceuticals Holding's market cap is $8.91B, based on a share price of $530.86 and 16.8M shares outstanding as of Jun 30, 2026.
Financials
Tonix Pharmaceuticals Holding reported revenue of $13.11M for fiscal 2025, up 29.85% from fiscal 2024.
Tonix Pharmaceuticals Holding reported a net loss of $124.02M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $13.11M | +29.9% | −$124.02M | −946.2% | −$14.57 | −$103.21M |
| FY2024ended Dec 31, 2024 | $10.09M | +29.9% | −$130.04M | −1,288.3% | −$176.60 | −$61.05M |
| FY2023ended Dec 31, 2023 | $7.77M | — | −$116.66M | −1,501.8% | −$14,720.25 | −$109.90M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $13.54M | −$40.55M | −$2.44 |
| Q1 FY2026ended Mar 31, 2026 | $6.88M | −$40.19M | −$2.93 |
| Q4 FY2025ended Dec 31, 2025 | $5.39M | −$46.91M | −$4.28 |
| Q3 FY2025ended Sep 30, 2025 | $3.29M | −$32.01M | −$3.59 |
| Q2 FY2025ended Jun 30, 2025 | $2.00M | −$28.27M | −$3.86 |
| Q1 FY2025ended Mar 31, 2025 | $2.43M | −$16.83M | −$2.84 |
| Q4 FY2024ended Dec 31, 2024 | $2.58M | −$22.11M | $2,302.65 |
| Q3 FY2024ended Sep 30, 2024 | $2.82M | −$14.21M | −$22.68 |
Company profile
- Name
- Tonix Pharmaceuticals Holding Corp.
- Ticker
- TNXP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 200 Connell Drive, Suite 3100, Berkeley Heights, NJ 07922
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001430306
Recent SEC filings
- Oct 2, 2026
- Sep 22, 2026
- Sep 8, 2026
- Aug 18, 2026
- Aug 10, 2026
- Aug 10, 2026
- Aug 3, 2026
- Jul 21, 2026
Frequently asked questions
What is Tonix Pharmaceuticals Holding's stock price?
Tonix Pharmaceuticals Holding (TNXP) closed at $530.86 on Oct 9, 2026, down 0.96% from the previous close of $536.02.
What is Tonix Pharmaceuticals Holding's market cap?
Tonix Pharmaceuticals Holding's market cap is $8.91B, based on a share price of $530.86 and 16.8M shares outstanding as of Jun 30, 2026.
How much revenue does Tonix Pharmaceuticals Holding make?
Tonix Pharmaceuticals Holding reported revenue of $13.11M for fiscal 2025, up 29.85% from fiscal 2024.
Does Tonix Pharmaceuticals Holding pay a dividend?
Tonix Pharmaceuticals Holding's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Tonix Pharmaceuticals Holding Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures